p53

Genetic polymorphisms in patients with endometriosis: an analytical study in Goiânia (Central West of Brazil)

K. S. F. Silva, Moura, K. K. V. O., Silva, K. S. F., and Moura, K. K. V. O., Genetic polymorphisms in patients with endometriosis: an analytical study in Goiânia (Central West of Brazil), vol. 15, p. -, 2016.

In healthy women, intra- and extracellular controls prevent the attachment and proliferation of ectopic endometrial cells. During endometriosis, abnormalities in these control mechanisms permit the survival of endometrial cells, their subsequent attachment to the peritoneal cavity, and disease progression. These abnormal cells cause invasion of tissues and induce an inflammatory response. Several genetic, immunological, and environmental factors contribute to this complex process.

Effect of SNX-2112 on proliferation of esophageal cancer cells via regulation of excision repair cross-complementing 1, epidermal growth factor receptor, and p53 expression

C. Y. Li, Ren, Y. J., Li, Y. D., Li, C. Y., Ren, Y. J., and Li, Y. D., Effect of SNX-2112 on proliferation of esophageal cancer cells via regulation of excision repair cross-complementing 1, epidermal growth factor receptor, and p53 expression, vol. 15, p. -, 2016.

SNX-2112 is a potential molecular targeted therapeutic drug against esophageal cancer (EC). However, its exact mechanism of action remains to be explained. The aim of this study was to investigate the effect of SNX-2112 on excision repair cross- complementing 1 (ERCC1), epidermal growth factor receptor (EGFR), and p53, to elucidate the mechanism of action of SNX-2112 on EC. Fresh tumor sections were surgically obtained from 65 patients with EC, and the expression of ERCC1, EGFR, and p53 was determined by immunohistochemical staining.

Borax-induced apoptosis in HepG2 cells involves p53, Bcl-2, and Bax

Y. Wei, Yuan, F. J., Zhou, W. B., Wu, L., Chen, L., Wang, J. J., Zhang, Y. S., Wei, Y., Yuan, F. J., Zhou, W. B., Wu, L., Chen, L., Wang, J. J., and Zhang, Y. S., Borax-induced apoptosis in HepG2 cells involves p53, Bcl-2, and Bax, vol. 15, p. -, 2016.

Borax, a boron compound and a salt of boric acid, is known to inhibit the growth of tumor cells. HepG2 cells have been shown to be clearly susceptible to the anti-proliferative effects of borax. However, the specific mechanisms regulating this effect are poorly understood. This study aimed to investigate the pathways underlying the growth inhibition induced by borax in HepG2 cells. The effects of borax on HepG2 cell viability were characterized using MTT. Apoptosis was also verified by annexin V/propidium iodide staining.

Subscribe to p53